Change in management structure at Santen Ltd

Article

Santen Pharmaceutical Co., Ltd., the Japanes ophthalmic pharmaceutical company, has announced that Adrienne Graves, PhD, president and chief executive officer (CEO) of its wholly-owned US subsidiary, Santen Inc., has resigned...

Santen Pharmaceutical Co., Ltd., the Japanes ophthalmic pharmaceutical company, has announced that Adrienne Graves, PhD, president and chief executive officer (CEO) of its wholly-owned US subsidiary, Santen Inc., has resigned and will continue to work with Santen as a strategic consultant and advisor to the Senior Management of Santen. Regarding the change, Mr. Akira Kurokawa, President and CEO of Santen Ltd., noted: “Dr. Graves built a strong US team, was responsible for obtaining three NDA approvals and is an active member on the boards of many ophthalmic organizations. We look forward to Adrienne’s continued contribution to Santen’s globalization initiatives as a strategic advisor on the development of the US market.”

With effect from April 1, 2010 Toshiaki Nishihata, PhD will become the CEO of Santen Inc. in addition to continuing in his current role as a Member of the Board, Senior Corporate Officer and Head of the Research and Development Division. Akihiro Tsujimura, who most recently was the Head of Business Development Department, will become the Chief Operating Officer (COO) of Santen Inc.

Mr Kurokawa noted that this change in management structure will support the increased focus on the US market as part of Santen's globalization initiative. “We are focused on building a robust global pipeline, particularly in support of an increased presence in the US market, and we are aggressively expanding our clinical and business development efforts to support the company's international expansion. This change in management structure will increase the communication and corporate focus on the US market,” stated Mr Kurokawa.

“The R&D staff at Santen Inc. will remain an integral part of our overall global efforts. They are an essential element as we advance our R&D initiatives. I am eager to take on this new role and lead the company to enhance our global, integrated approach to R&D,” Dr Nishihata commented.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.